Thursday, 3 August 2006
|
| Celebrex Renee S 05:58:56 |
| | Hi all,
I haven't been in here for a long time but I just thought I'd stop in to
see what's being said about Celebrex. I take a 200mg capsule twice a
day.
Wondering what I will take if they pull this drug from the doctors. I
have been without and I can't move well after five days of not having
it. I am also taking Enbrel and Darvacet.
I haven't talked with my Dr. yet. I have an appointment on the Jan 27.
Just wondering,
Renee
|
| |  12 answers | Add comment |
|
| Back Pain & Disability Countrygirl 05:29:21 |
| | Hi, I'm new to this site and am glad I ran across it. I have /had
degenerative disk disease since 2003, just started hurting one day and had to
have surgery 6 months later. Nothing worked to help the pain. I had a
diskectomy, laminectomy with fusion of L4&5 with Bone Morphogenic Protein.
After the surgery I did fairly well then started hurting really bad again.
Doc thought I might had another bad disc but I didin't, the pain continued
and worsened. He went in and did another surgery and removed the hardware
and did another laminectomy. I am still hurting!!! He says he can't
understand why but that there are a lot of things they still don't know in
the medical field. I am now scheduled to go to a Pain Clinic next week.
I filed for my SSD in January of 2006, was denied in May, I have hired an
attorney and am appealing. I am unable to sit or stand for any extended
periods of time. We have been forced to file bankruptcy and now I have more
medical bills to pay. What a shame it takes so long for people who need help!
I have been told my problem is hard to prove to get disability. Can anyone
give me the average length of time it takes if you are approved? I hate
going thru this. It took me a while to accept that I was going to have to
file for it. Guess I should have done it sooner.
|
| | 5 answers | Add comment |
|
| Inet drug sales busts Califchief 04:37:00 |
| | Internet Pharmacy Doctors Charged With Peddling Diet Drugs
08-02-2006 18:58
MARYCLAIRE DALE
PHILADELPHIA -- Two doctors helped peddle millions of
dollars' worth of diet drugs through an online pharmacy,
approving thousands of prescriptions without seeing
anyone in person, according to charges filed Wednesday.
By signing off on the orders, Doctors Ranvir Ahlawat and
Steven Klinman helped RxMedicalOne.com take in $33.6
million in nine months, according to the indictment.
Most of the orders were for highly addictive, controlled
drugs, they said.
"This is high-tech drug dealing," said U.S. Attorney
Patrick Meehan.
Ahlawat, 42, of Toms River, N.J., and Klinman, 57, of
Elkins Park, Pa., reviewed the questionnaires customers
sent in with their orders, prosecutors said. Ahlawat
reviewed 1,000 to 1,500 a day at times.
Their lawyers did not immediately return calls Wednesday.
A message left after-hours with RxMedicalOne.com also
went unreturned.
Prosecutors said more people could be charged in the
case. They said five doctors approved more than 350,000
prescriptions from September 2003 to May 2004, most for
weight-loss drugs such as Phentermine and Adipex and
sleep aids such as Ambien.
The indictment also charges pharmacy operator Michael
Bezonsky; pharmacist Alexander Atchildiev, who is accused
of shipping the drugs without ensuring the prescriptions
were valid; and Thomas Beaulieu, who helped Bezonsky run
the business.
"Fundamentally, the government's theory is that every
prescription requires a face-to-face meeting with the
equivalent of Dr. Welby, and that is out of step with
the Internet world," said Bezonsky's lawyer, John M.
Vandevelde.
A lawyer for Atchildiev did not immediately return a
call. Beaulieu's lawyer, Benjamin Gluck, said his
client was charged under a statute in which criminal
intent is not required.
... D‚j… Flu: Being sick and tired of being sick and tired.
|
| | Add comment |
Wednesday, 2 August 2006
|
| Surgeon General's Report Califchief 23:32:00 |
| | The 2004 surgeon General's Report
on Bone Health and Osteoporosis
WHAT IT MEANS TO YOU
Weak Bones Hurt Us All
Why Helty Bones Are Important to You
Don't Risk Your Bones
Bones are not what you think they are
When Bones Break
You could be at risk
Bone Up On Your Diet
Protect your bones at every age
(much more)
To order copies of this booklet or the full
Surgeon General's report, BONE HEALTH AND
OSTEOPOROSIS: A SURGEON GENERAL'S REPORT,
call toll free 1-866-718-BONE
More information about the Surgeon General's
Report is available at:
http://www.surgeongeneral.gov
More facts and advice are available from:
National Institutes of Health Osteoporosis and
Related Bone Disease - National Resource Center
2 AMS Circle
Bethesda, MD 20892-3676
http://www.niams.nih.gov/bone
... What's so funny about the funny bone?
|
| | Add comment |
|
| Novel approach to the treatment of RA Ironjustice@Aol.Com 20:33:47 |
| | <<snip>>
IL-6 is a candidate target for therapeutic inhibition
<<snip>>
http://arthritis-research.com/content/8/S2/S4
Because of the central role played by IL-6 in a number of
manifestations of these inflammatory diseases, IL-6 is a candidate
target for therapeutic inhibition as a novel approach to the treatment
of RA, sJIA and perhaps other related rheumatic diseases.
---------------------------------------------------------------------------В--------------------------
Induction of interleukin-6 by coal containing bioavailable iron is
through both hydroxyl radical and ferryl species.
Zhang Q, Huang X
J Biosci. 2003 Feb ; 28(1): 95-100
Coal mining causes health problems, such as pneumoconiosis. We have
previously shown that prevalence of pneumoconiosis in workers from
various coalmine regions positively correlates with levels of
bioavailable iron (BAI) in the coals from that region. In the present
study, the nature of reactive oxygen species formed by BAI in the coals
and its mechanisms of the induction of biological responses were
investigated. Human lung epithelial cell line, A549 cells, were used to
examine the induction of interleukin-6 (IL-6), a pro-inflammatory
cytokine, which is known to play a crucial role in the development of
pneumoconiosis. We found that levels of IL-6 protein as well as its
mRNA were significantly increased in the cells treated for 24 h with 20
microg/cm2 of the BAI-containing Pennsylvania (PA) coal; for example we
observed 6.7-fold increase in IL-6 protein. Levels of IL-6 protein in
cells treated with the Utah (UT) coal containing low-BAI were only
1.9-fold of the control levels. The enhancing effect on the IL-6 by the
PA coal was similar to that caused by hydrogen peroxide. Superoxide
dismutase (SOD), catalase (CAT), and N-acetyl-L-cysteine (NAC) all had
inhibitory effects on the PA coal-induced IL-6 formation. However, CAT
had the least protective effect as compared to SOD and NAC. Our results
indicate that BAI in the PA coal may induce IL-6 through both ferryl
species (via iron autoxidation) and hydroxyl radicals (via the
Fenton/Haber Weiss reactions).
Who loves ya.
Tom
Jesus Was A Vegetarian!
http://jesuswasavegetarian.7h.com
Man Is A Herbivore!
http://tinyurl.com/a3cc3
DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk
|
| | 1 answer | Add comment |
|
| OTP: McAfee problems Califchief 16:27:00 |
| | McAfee Security Programs May Expose Passwords,
Other Sensitive Data, Researchers Say
07-31-2006 18:55
By DAN GOODIN
SAN FRANCISCO -- Consumer versions of McAfee
Inc.'s leading software for securing PCs is
susceptible to a flaw that can expose passwords
and other sensitive information stored on
personal computers, researchers said Monday.
The vulnerability affects many of McAfee's most
popular consumer products, including its
Internet Security Suite, SpamKiller, Privacy
Service and Virus Scan Plus titles, said Marc
Maiffret, chief hacking officer at eEye Digital
Security Inc., a competing maker of security
products.
McAfee spokeswoman Siobhan MacDermott confirmed
the vulnerability and said software engineers
were testing a fix. She said officials expected
to release the patch Wednesday using a feature
that automatically updates McAfee products over
the Internet. The flaw does not affect 2007
versions of McAfee products, which were released
Saturday, she said.
Maiffret said he has found a way to connect to
PCs running the flawed McAfee products over the
Internet and make them run code of his choosing.
The flaw, if exploited, would make it possible
for a criminal to track bank account numbers,
and access, modify and delete sensitive files
and do other damage on machines running the
McAfee products, he said.
The reported flaw came on the same day that
McAfee posted an item on its Web site taking a
swipe at Microsoft Corp., whose products
increasingly compete with the offerings of
McAfee, Symantec Corp. and other security
companies. It warned that code had been released
that exploited flaws in a feature used to
automate certain administrative tasks in
Microsoft's Windows operating system.
"Microsoft products have always been an
attractive target for hackers and malware
authors," according a posting on the McAfee Web
log.
Maiffret's company, which in the past has
discovered embarrassing flaws in products sold
by Apple Computer Inc., Microsoft, Symantec and
McAfee, said he was withholding technical
details of Monday's vulnerability to prevent
criminals from learning how to exploit it.
The flaw comes two weeks after Aliso Viejo,
Calif.-based eEye disclosed a hole in a McAfee
program for protecting business computers. In
that case, Santa Clara, Calif.-based McAfee said
it had fixed the defect three months earlier but
did not warn customers about it until eEye made
it public.
In May, eEye uncovered a similarly dangerous
flaw in security software by Symantec.
Neither Maiffret nor McAfee said they were aware
of any attacks that target the flaw disclosed on
Monday.
"The vulnerability isn't public, so you
shouldn't see exploits for it," Maiffret said,
adding that users of McAfee products should make
sure they are configured to automatically check
for updates each day.
___
On the Net:
http://www.eeye.com
http://www.avertlabs.com/research/blog/?p63
... Epitaph: DRACULA -- Down For The Count
|
| | Add comment |
|
| Chikungunya to cure Arthritis? Gerhard Nowak 12:19:39 |
| | Hi there,
I didn't post yet on this forum, although I have Arthrosis in my knees since
8 years.
I had to stop sports two years ago, because my knees started swelling from
inside
after training hours and it took approx. 2 weeks to diminish after.
Recently I got the Mosquito disease "Chikungunya" which is the same like
"Ross River Fever" , a malaria kind of infection.
I had terrible pains in all my joints during the last 3 months and I felt
like 10 years older.
Actually the point is, that now, after all the symptoms are gone, the
swelling is gone as well!
I tried running on the beach - I am living on the Island of Mauritius -
excessively, and ......
I couldn't believe it..... there was no swelling of my knees anymore! And I
don't take tablets
or else, never.
Is this only temporarily or did I find the real cure for the Arthritis?
Would like to have soime more opinions.
Gerry
|
| | 1 answer | Add comment |
|
| Ping: Squirrely Gary Z 07:17:57 |
| | Hi Jo,
I got your email at home and tried to respond but for some reason I can't
get to my outgoing mail server.
You asked about Mike's b'day. It is the 14th of Nov. and he just turned 14.
Things are going pretty well. Am back at work now and just catching up on
mail and everything. Not many people here today, so it is a good day for it.
Don't see the doc 'till the 1st of Feb. for the elbow.
Take care.
GaryZ
|
| | 8 answers | Add comment |
|
| Clinical trials Califchief 07:00:00 |
| |
Think this may also apply to arthritis drugs?
I've noticed more and more display ads (the
big ones with pictures) asking for volunteers.
{Exceprts from the below URL and tonight's broadcast}
http://abcnews.go.com/US/popup?id=2262371
ABC News
August 1, 2006
Experts Weigh In: Shortage of Patients In Cancer Trials
Doctors Grapple With Lack of Volunteers for Cancer Studies
"We have a lot of trials where we can't get enough
patients, the trial closes early, and that means agents
(drugs) that might show a lot of promise in treating
cancer never get to the market........"
Dr. Julie Vose, chief of oncology/hematology at the
University of Nebraska Medical Center
The American Cancer Society offers a computerized
service that compares each patient's medical situation
(such as type of cancer, how far it has spread, any
treatments they have already had) and personal
preferences, with the inclusion and exclusion criteria
for thousands of cancer clinical trials."
Dr. Ted Gansler, director of medical content,
American Cancer Society
There are more than 400 cancer drugs now in
clinical trials, many of which are experimental
medicines with the potential to treat some of
the most lethal and common forms of cancer.
The only problem is that researchers are
running out of cancer patients to test all
these new drugs on.
"Only about 3 percent of cancer patients
participate in cancer clinical trials," said
Dr. Robert Comis, a clinical trial expert and
board president of the Coalition of Cancer
Cooperative Groups.
Surprisingly, the most common reason patients
don't enroll is that they don't know they can.
The Coalition of Cancer Cooperative Groups did
a recent survey and found that only 10 percent
of cancer survivors knew of any clinical trial
for their specific cancer.........because only
10 percent of doctors tell patients about them.
... (A)bort, (R)etry, (I)gnore, (S)orry I Asked
|
| | Add comment |
Tuesday, 1 August 2006
|
| back to the doc again Becky 23:04:14 |
| | Hi all,
I go back to the foot doctor again tomorrow, I have been trying to get some
good custom orthodics made and it is taking forever, the first pair was so
wide wouldn't fit in any shoe, so went back and he cut them a small amount
the plastic hurts my arch sometime but tried to get another pair of shoes,
since they discontinued the one I was wearing, anyway orthodic was still a
little bit to big in heel so took back, well he made it narrow alright but
now when I put my foot on it is almost all the way off the arch, so back
again tomorrow and I am sure I will need a new pair and I don't think I
should have to pay another 400 for them.
My feet have been hurting which makes my back hurt, but lately I noticed
that the toes fell like they are on fire and at night you feel pains in the
base of both big toes, when RA is acting int he feet what exactly do you
feel? When I was first diagnosed I have erosions in the 1 and 5 metatarsal
so they were there, and then been on enbrle and mtx but the last foot x-rays
should some more erosions, so I am not sure if hits is working, but I had
only been on enbrel a month before those pics had been taken so it could
have been from the years with just mtx.
I am so discouraged, the feet hurt which makes the back bad, it was spasms
last night and I was told that RA has nothing to do with the back hurting so
I am at a loss.
How do you know when your RA is progressing> I have an appt with the RA doc
in 3 weeks so I will talk to him also, he may suggest Remicade, but I am not
sure about hat one, since I have heard so ,many people say that they get
allergic reactions.
Well any infor would be great
Thanks
Becky
|
| | 4 answer | Add comment |
|
| Efficacy of Glucosamine and Chondroitin Sulfate Ironjustice@Aol.Com 22:50:16 |
| | <<snip>>
CONCLUSIONS: Combination Glucosamine and Chondroitin Sulfate is
effective in treating moderate to severe knee pain due to OA.
<<snip>>
http://tinyurl.com/f3erz
Title: The Efficacy of Glucosamine and Chondroitin Sulfate in Patients
with Painful Knee Osteoarthritis (OA): The Glucosamine/chondroitin
Arthritis Intervention Trial (GAIT)
Category: 7. Osteoarthritis-clinical aspects
Author(s): Daniel O. Clegg1, Domenic J. Reda2, Crystal L. Harris3,
Marguerite A. Klein4, for the GAIT Investigators. 1University of Utah,
Salt Lake City, UT; 2VACSP, Hines, IL; 3VACSP, Albuquerque, NM;
4NCCAM/NIH, Bethesda, MD
Presentation Number: 622
Abstract: PURPOSE: Glucosamine (G) and chondroitin sulfate (CS) are
widely promoted to "reduce joint pain and provide support for healthy
cartilage and joint function." GAIT was designed to rigorously assess
the efficacy and safety of these agents alone and in combination. G and
CS were required to meet pharmaceutical standards as GAIT was conducted
under an Investigational New Drug application.
METHODS: Patients were =40 years of age with knee pain (WOMAC Pain
125-400 mm) of at least 6 months duration and x-ray evidence of knee OA
[Kellgren-Lawrence (KL) Grades 2 or 3]. Patients were randomly assigned
double-blind to placebo (P); G(Glucosamine HCl 500 mg) tid; Sodium CS
400 mg tid; G+CS at the above doses tid; or celecoxib (CE) 200 mg
daily. All patients were allowed up to 4000 mg daily of acetaminophen
(APAP) as rescue analgesia, except within 24 hours of study visits.
Allocation was stratified by Center and by WOMAC Pain severity
(125-300mm and 301-400mm). Patients were evaluated at baseline and
weeks 4, 8, 16 and 24. The primary outcome measure was a 20%
improvement from baseline in WOMAC Pain at week 24. Adverse events were
documented at each visit. Analysis was based on intention-to-treat.
RESULTS: 3238 patients were screened at 16 US academic rheumatology
centers. 1583 were randomized and 1258 (80%) completed the study.
Baseline characteristics were: mean age 58.6 years, BMI 31.7 kg/m2, OA
symptoms 10 years, 64% female, summed mean WOMAC Pain 236В±73mm (206mm
for 125-300mm stratum, 341mm for 301-400mm stratum), 59% KL Grade 2,
and 78% were in the 125-300mm WOMAC Pain stratum and were evenly
distributed across all arms.
The response rate for CE (70.1%) was higher than the response rate for
P (60.1%) in the primary outcome analysis of all patients (p=0.008). In
the 301-400 mm WOMAC pain stratum, the response rate for G+CS (79.2%)
was higher than P (54.3%) (p=0.002). Secondary outcomes in the 301-400
mm stratum, including 50% WOMAC Pain response, WOMAC Stiffness, WOMAC
Function, HAQ, patient assessments, and use of rescue APAP all
demonstrated changes consistent with the primary outcome. Adverse
events were generally mild and evenly distributed among the groups.
Response Rates by Treatment Group and Pain Stratum
All patients WOMAC Pain 301-400mm WOMAC Pain 125-300mm
P 60.1% 54.3% 61.7%
CE 70.1%** 69.4%В¶ 70.3%*
G 64.0% 65.7% 63.6%
CS 65.4% 61.4% 66.5%
G+CS 66.6%+ 79.2%# 62.9%
** p= 0.008 CE vs. P
+ p= 0.09 G+CS vs. P В¶p = 0.06 CE vs. P
# p = 0.002 G+CS vs. P * p= 0.04 CE vs. P
CONCLUSIONS: Combination G+CS is effective in treating moderate to
severe knee pain due to OA. The lack of response in patients with mild
pain may be due to a floor effect, limiting ability to detect response.
All study agents were well tolerated.
2005 Program Planner
American College of Rheumatology
1800 Century Place, Suite 250
Atlanta, GA 30345
Who loves ya.
Tom
Jesus Was A Vegetarian!
http://jesuswasavegetarian.7h.com
Man Is A Herbivore!
http://tinyurl.com/a3cc3
DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk
|
| | 1 answer | Add comment |
|
| glucosamine & chondroitin Califchief 22:14:00 |
| | RESULTS OF GLUCOSAMINE, CHONDROITIN NIH TRIALS ARE HAZY
The long-awaited National Institures of Health-funded
research trial on the use of glucosamine & chondroitin
for osteoarthrits have been completed.
Conflicting media interpretations - some saying these
dietary supplements work, and other saying they're a
waste of money - leave consumers stranded between two
extremes.
So what to think?
The six-month, double-blind placebo study evaluated
glucosamine hydrochloride and chondroitin sulfate for
treatment of OA-related knee pain. The 1,583 patients
were classified as having either mild knee pain or
moderate-to-severe knee pain. Most had mild knee pain.
Participants were divided in five groups, each taking
one of the following: > Glucosamine hydrochhloride, 500mg three times daily. > Chondroitin sulfate, 400mg three times daily. > Glucosamine-chondroitin combination in above doses. > Celecoxib (Celebrex), 200mg daily. > Placebo pills.
To be included in the results, participants had to
experience at least a 20% decrease in pain.
The results are somewhat surprising. Those taking
the placebo had a very high response rate (60.1%).
All participants considered, glucosamine and
chondroitin were no better than the placebo in
reducing knee pain. Only celecoxib, the prescription
non-steroidal anti-inflammatory (NSAID), worked better
than the placebo, though just 10% better.
There was good news, howver, in the smaller number of
participants with moderate-to-severe knee pain: the
glucosamie-chondroitin combination worked 25% better
than the placebo for relieving more severe pain.
Interestingly, chondroitin alone was found to reduce
swelling in those who had swelling or fluid in the
knee, while the glucosamine-chondroitin combination
did not.
The bottom line: glucosamine and chondroitin are
deemed generally safe and might be worth trying for
OA, with glucosamine sulfate as perhaps the first
choice. Those with more severe pain may wish to use
a glucosamine-chondroitin combination product.
Keep in mind that it may take up to 2 months to see
any benefits.
... 98% of all dead owls don't give a hoot!
|
| | Add comment |
|
| Prescription requests Kdb4ut 22:12:37 |
| | I was told over a year ago, I had Gout. I am a female only 35 years
old. I was on Indocine and Cholcine, with Ultram for the pain. My
most recent doctor was continuing to prescribe this to me, until she
realized that I was taking the Ultram and not the other two for pain.
She quickly referred me to a RM. Today I went was was told that I did
not have Gout, it was somewhat impossible at my age and with being
female. He suggested I continue on the Ultram 100mg a day. However,
should I ask for some tpe of Celebrex with it? Whatelse can I take
with Ultram?
|
| | 3 answer | Add comment |
|
| OA clinical trials Califchief 22:12:00 |
| | Osteoarthritis Clinical Trial - Novartis Clinical Trials
Learn about the Osteoarthritis clinical trial at Novartis
and see if you qualify to participate in one.
http://www.novartisclinicaltrials.com/etrials/home.do
(You will see a list of trial - click on osteoarthritis)
Osteoarthritis
This common degenerative joint disease is an expression of
'wear-and-tear'. Thus athletes or overweight people develop
osteoarthritis in large joints (knees, shoulders, hips) due
to loss or damage of cartilage. When cartilage is lost, the
bone next to the joint is also eroded. There is some
inflammation, but not as much as in other types of arthritis.
Nevertheless, osteoarthritis is responsible for considerable
pain and disability in older persons.
Novartis Pharmaceuticals Corporation is currently seeking
patients to participate in the following clinical trials
Please review the description(s) of the clinical trial(s)
listed below and click on the one that best suits your condition.
When you click on a study, you will be presented with a
questionnaire to see if you (or the patient for whom you are
answering) meet the preliminary qualifications for this study.
If you or the patient meet these qualifications, a list of
participating study centers will be displayed. Select the
study center nearest you (or the patient) for additional
information about this clinical trial.
All clinical trial participants will be required to sign an
informed consent with the study center prior to enrolling in
the study. Novartis recommends that you consult your doctor
before participating in a clinical trial.
Novartis Pharmaceuticals Corporation is conducting a clinical
research study to evaluate the effectiveness of the drug
lumiracoxib for the treatment of osteoarthritis in people who
are 50 years of age and older and have controlled high blood
pressure. The study will examine if the drug lumiracoxib taken
in combination with the patient's current high blood pressure
medication, impacts their blood pressure when compared to
ibuprofen. Each patient will have an equal chance of
miracoxib or ibuprofen. The combination of these drugs are
considered "investigational". An "investigational drug" is a
drug that is being tested and is not approved for sale in the
United States by the U.S. Food and Drug Administration (FDA).
Trial phase: Phase 4
Participation Duration: There will be 5 scheduled study visits
over a 5 week period between the hours of 7AM and 11AM.
Protocol Number: CCOX189A2428
... Why do psychics have to ask you for your name?
|
| | Add comment |
|
| OTP: McAfee news Califchief 18:50:00 |
| | McAfee Security Programs May Expose Passwords,
Other Sensitive Data, Researchers Say
07-31-2006 18:55
By DAN GOODIN
SAN FRANCISCO -- Consumer versions of McAfee
Inc.'s leading software for securing PCs is
susceptible to a flaw that can expose passwords
and other sensitive information stored on
personal computers, researchers said Monday.
The vulnerability affects many of McAfee's most
popular consumer products, including its
Internet Security Suite, SpamKiller, Privacy
Service and Virus Scan Plus titles, said Marc
Maiffret, chief hacking officer at eEye Digital
Security Inc., a competing maker of security
products.
McAfee spokeswoman Siobhan MacDermott confirmed
the vulnerability and said software engineers
were testing a fix. She said officials expected
to release the patch Wednesday using a feature
that automatically updates McAfee products over
the Internet. The flaw does not affect 2007
versions of McAfee products, which were released
Saturday, she said.
Maiffret said he has found a way to connect to
PCs running the flawed McAfee products over the
Internet and make them run code of his choosing.
The flaw, if exploited, would make it possible
for a criminal to track bank account numbers,
and access, modify and delete sensitive files
and do other damage on machines running the
McAfee products, he said.
The reported flaw came on the same day that
McAfee posted an item on its Web site taking a
swipe at Microsoft Corp., whose products
increasingly compete with the offerings of
McAfee, Symantec Corp. and other security
companies. It warned that code had been released
that exploited flaws in a feature used to
automate certain administrative tasks in
Microsoft's Windows operating system.
"Microsoft products have always been an
attractive target for hackers and malware
authors," according a posting on the McAfee Web
log.
Maiffret's company, which in the past has
discovered embarrassing flaws in products sold
by Apple Computer Inc., Microsoft, Symantec and
McAfee, said he was withholding technical
details of Monday's vulnerability to prevent
criminals from learning how to exploit it.
The flaw comes two weeks after Aliso Viejo,
Calif.-based eEye disclosed a hole in a McAfee
program for protecting business computers. In
that case, Santa Clara, Calif.-based McAfee said
it had fixed the defect three months earlier but
did not warn customers about it until eEye made
it public.
In May, eEye uncovered a similarly dangerous
flaw in security software by Symantec.
Neither Maiffret nor McAfee said they were aware
of any attacks that target the flaw disclosed on
Monday.
"The vulnerability isn't public, so you
shouldn't see exploits for it," Maiffret said,
adding that users of McAfee products should make
sure they are configured to automatically check
for updates each day.
___
On the Net:
http://www.eeye.com
http://www.avertlabs.com/research/blog/?p63
... Betty Crocker was a flour child.
|
| | Add comment |
|
| Re: Squirrely Jo Firey 09:23:46 |
| |
"Gary Z" <dadandone@N_O_S_P_A_Mearthlink.net> wrote in message
news:crbsg6$cfc$1@usenet.cso.niu.edu...> Hi Jo,> I got your email at home and tried to respond but for some reason I can't> get to my outgoing mail server.> You asked about Mike's b'day. It is the 14th of Nov. and he just turned> 14.> Things are going pretty well. Am back at work now and just catching up on> mail and everything. Not many people here today, so it is a good day for> it.> Don't see the doc 'till the 1st of Feb. for the elbow.> Take care.> GaryZ>
Tell Mike it is a very good day for a birthday. It was my Aunt Ena's
birthday. And it is my husband Charlie's birthday. Also Prince Charles and
also my niece Dawn.
As Charlie points out, he wasn't born on the princes birthday, the prince
was born on him. He's older.
|
| | 22 answer | Add comment |
|
| Wellnews - ALL THE FACTS THAT FIT Fire Chief 08:46:11 |
| | PHOBIA OF THE WEEK
Rhypophobia - fear of getting wrinkles
BEST MEDICINE
A guy spots his doctor in a shopping mall.
He stops him and says, "Six weeks ago
when I was in your office, you told me to
go home, get into bed and stay thery until
you called."
"I didn't?" replied the doctor.
"Then what are you doing out of bed?"
PROTEIN AND MIDLIFE MUSCLE
Hanging o to midlife muscle is much easier
than trying to regain it later, a University of
Texas study says. Muscle biopsies conducted
on study participants (average age 68) found
that their muscles had assimilated 71% fewer
amino acids from protein than younger subjects.
Recommended protein levels for those over 50:
46 grams for women and 56 grams for men.
... Bureaucat: A kitty who sleeps on your underwear.
|
| | Add comment |
|
